(Q73093094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

John Wagstaff

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

A Baars

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A M Claessen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A J van den Eertwegh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H E Gall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A G Stam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Meijer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C J Meijer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R J Scheper

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J B Vermorken

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H M Pinedo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

965-970

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

New approaches to the systemic treatment of melanoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

The role of adoptive immunotherapy in solid cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

The use of interferon-alpha in the treatment of cutaneous melanoma: a review.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

1 reference

7 January 2021

Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Vaccine therapy for malignant melanoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Correlation of tuberculin induration with the number of Bacillus Calmette-Guérin vaccines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008363601515

7 January 2021

Identifiers

DOI

10.1023/A:1008363601515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11038032%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference